Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease

Cited by (281)

Items 201–281 of 281

1. Proteome and phosphoproteome profiling of non‐small cell lung cancer cell line A549 treated with TRAIL
   Yi Zhong, Fen Yang, Tao Su, Xiyu Wu, Wen Li Zheng, Lu Zhang, Liang Ge, Lian Y. Wang, Shisheng Wang, Shisheng Wang et al. · 2022 · PROTEOMICS
2. Integrated proteomic and phosphoproteomic data-independent acquisition data evaluate the personalized drug responses of primary and metastatic tumors in colorectal cancer
   Xumiao Li, Yiming Huang, Kuo Zheng, Guanyu Yu, Qinqin Wang, Lei Gu, Jingquan Li, Hui Wang, Wei Zhang, Yidi Sun et al. · 2023 · Biophysics Reports
3. Identifying Sex-Specific Serum Patterns of Alzheimer’s Mice through Deep TMT Profiling and a Concentration-Dependent Concatenation Strategy
   Kaushik Kumar Dey, Jay M. Yarbro, Danting Liu, Xian Han, Zhen Wang, Yun Jiao, Zhiping Wu, Shu Yang, Dong Geun Lee, Abhijit Dasgupta et al. · 2023 · Journal of Proteome Research
4. Evaluating the associations between intelligence quotient and multi-tissue proteome from the brain, CSF and plasma
   Sirong Shi, Yujing Chen, Xiaoge Chu, Panxing Shi, Bingyi Wang, Qingqing Cai, Dan He, Na Zhang, Xiaoyue Qin, Wenming Wei et al. · 2024 · Brain Communications
5. Omics for Biomarker Investigation in Neurodegenerative Diseases
   Aiman Tanveer, Dinesh Yadav · 2022 · BENTHAM SCIENCE PUBLISHERS eBooks
6. Future Advances in Early Phase Clinical Development for Disease Modifying Therapies for Neurodegenerative Diseases
   Philip H.C. Kremer, Geert Jan Groeneveld · 2022 · Medical Research Archives
7. Artificial intelligence in mass spectrometry-based proteomics
   Wen‐Feng Zeng, Matthias Mann, Maximilian T. Strauss · 2023 · Elsevier eBooks
8. The Research Progress of the Application of Bioinformatics in the Diagnosis and Treatment of Alzheimer's Disease
   Zhiyang Yu, Wenpan Wang, Qiong Qiao, Yiran Sun, Zhishen Xie, Junying Song, Zhenqiang Zhang, Huifen Ma · 2024 · Chinese medicine and natural products
9. PERCEPT: Replacing binary p-value thresholding with scaling for more nuanced identification of sample differences
   Dezerae Cox, Danny M. Hatters · 2024 · iScience
10. Modified Decision Tree with Custom Splitting Logic Improves Generalization across Multiple Brains’ Proteomic Data Sets of Alzheimer’s Disease
    Mark V. Ivanov, Anna S. Kopeykina, Elizaveta M. Kazakova, Irina A. Tarasova, Zhao Sun, Valeriy I. Postoenko, Jing-Hua Yang, Mikhail V. Gorshkov · 2025 · Journal of Proteome Research
11. Coagulation functions and factors correlated with central nervous system infection in herpes zoster patients
    Yanrong Yuan, Jing Gu, Huili Liu, Yu Wang, Zeyu Sun, Dongli Pan, Yongxing Yan · 2025 · Frontiers in Immunology
12. Proteomic profiling of cerebrospinal fluid reveals pathophysiology changes and diversity of treatment response in pediatric Streptococcus pneumoniae meningitis
    Jing Wei, Binglin Jian, Liang Zhu, Linyun Guo, Juan Du, Yuncui Yu, Xixi Zhang, Yunyan Wu, Wei Sun, Zhengguang Guo et al. · 2025 · Expert Review of Proteomics
13. Cerebrospinal fluid proteomic analysis of long-term antihypertensive treatment with amlodipine and atenolol in hypertensive rats
    Nina G. Smets, Betty Marije Tijms, Judith de Vos, Sander R. Piersma, Thang V. Pham, Connie R. Jiménez, Erik N.T.P. Bakker, Daphne M. P. Naessens · 2025 · Scientific Reports
14. Precision medicine in neurodegenerative diseases: From research to clinical practice
    Baskaran Gunasekaran, Amar Harris Arifin, Wong Hong Yu, Saema Hanafi, Kirtana Devi Kumara Rao, Shamala Salvamani · 2025 · Progress in brain research
15. Proteome-wide association study identifies novel Alzheimer's disease-associated proteins
    Lingyun Sun, Guikang Wei, Feiyang Ji, Yihong Ding, Jiayao Fan, Yue Xu, Chunfeng He, Yuan Zhou, Z. Liu, Zeyu Sun et al. · 2025 · Journal of Alzheimer s Disease
16. Shake and bake: a robust and cost-effective proteomic sample preparation workflow for plasma and cerebrospinal fluid
    John Rönnholm, Sophia Weiner, Johannes Fuchs, Annika Thorsell, Carina Sihlbom, Laura Dugom, Amy E. Easton, Henrik Zetterberg, Johan Gobom · 2026 · Clinical Proteomics
17. Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
    Marijke E. Stokkel, Lisa Vermunt, Jaco C. Knol, Davide Chiasserini, Lucilla Parnetti, Sander R. Piersma, Thang V. Pham, Richard R. de Goeij‐de Haas, Afina Willemina Lemstra, Yolande A.L. Pijnenburg et al. · 2026 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
18. Targeting tau-mitochondrial crosstalk in Alzheimer’s disease with an Integrative multi-omics and artificial intelligence driven tools for the development of disease-modifying therapeutics
    Shanmugam Bhasha, Vivek Chintada, Dr Manne Munikumar, Jagadeesh Maddineni, Raghuvardhan Nagulavancha, Thejomayi Malempati, Sai Swapna Gadda, Kiran Kumar Reddy Sankepally, Jangampalli Adi Pradeepkiran · 2026 · Ageing Research Reviews
19. Idiopathic Intracranial Hypertension Is Characterized by a Distinct Proteomic Profile
    Santosh Bhosale, Arkadiusz Nawrocki, Johanne Juhl Korsbæk, Nadja S. Hansen, Fabian Foettinger, Nik Krajnc, Mathias J. Norvig, Nora Eriksen, Stefan Macher, Berthold Pemp et al. · 2026 · Annals of Neurology
20. From prediction to mechanism: Explainable AI uncovers plasma and CSF proteomic signatures of Alzheimer's disease
    Turker Berk Donmez, MohammedMansour · 2026 · Journal of Proteomics
21. Artificial Intelligence for Integrated Analysis of Non-Blood Biological Fluids: From Biomarker Discovery to Clinical Decision-Support Systems
    Valentina Becherucci, Francesca Romano, Edda Russo · 2026 · Diagnostics
22. A peripheral proteomic signature of Alzheimer’s disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic: the BIOPEXAL study
    María Capdevila-Bayo, Rosanna Rossi, Itziar de Rojas, Raquel Puerta, Laura Guzman, Marina Carrasco, Álvaro Muñoz-Morales, Clàudia Olivé, Laura Montrreal, Pablo García‐González et al. · 2026 · Journal of Nanobiotechnology
23. ProFormer: generalizable classification of single-cell and plasma proteomes using deep learning
    Karl Kristian Krull, Arlene Kühn, Julia Höhn, Syed Azmal Ali, Martin H. Otterbein, Titus J. Brinker, Jeroen Krijgsveld · 2026 · Nature Communications
24. Targeting PAAN/MIF nuclease activity in parthanatos-associated brain diseases
    Lauren C. Guttman, Yang Liu, Meilian Liu, Valina Lynn Dawson, Ted M. Dawson · 2025 · Advances in pharmacology
25. Recent Advances in Human Cerebrospinal Fluid Proteomics
    Joaquín Fernández‐Irigoyen, Enrique Santamaría · 2025 · Methods in molecular biology
26. CSF factors in memory function
    Charlotte Elisabeth Teunissen, Jinte Middeldorp · 2022 · The Lancet Neurology
27. Perspective Chapter: Pattern Recognition for Mass-Spectrometry-Based Proteomics
    Patrick D. Bangert, Nandha Kumar Balasubramaniam, Carol E. Parker, Christoph H. Borchers · 2022 · Biomedical engineering
28. Proteomics As A Valid Tool In Biomarker Discovery For Alzheimer's Disease
    Valeria Magnelli · 2024 · Preprints.org
29. Bridging Health Disparity Gaps in Alzheimer’s Disease among Marginalized Populations: Clinical Proteomics as a Case Study
    Henry A. Adeola, Renã A. S. Robinson · 2025 · ACS Bio & Med Chem Au
30. Proteomic profiling of CSF reveals stage-specific changes in Amyotrophic lateral sclerosis patients
    Neža Cankar, Filippa Liliendahl Qvist, Anne S. Frahm, Katrine Pilely, Kirsten Svenstrup, Stephen Wørlich Pedersen, Anne-Lene Kjældgaard, Peter Garred, Niels Henning Skotte · 2026 · medRxiv
31. Preparação de nanoesfera magnética funcionalizada com L-histidina para o enriquecimento de proteínas de baixa abundância em amostra de soro sanguíneo: um foco em biomarcadores de doenças humanas
    Edileuza Marcelo Vieira · 2023
32. Additional file 3 of A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease
    Annett Boeddrich, Christian Haenig, Nancy Neuendorf, Eric Blanc, Andranik Ivanov, Marieluise Kirchner, Philipp Schleumann, Irem Bayraktaroğlu, Matthias Richter, Christine Molenda et al. · 2023 · Figshare
33. Additional file 1 of Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
    Bai, Bing, David Vanderwall, Yuxin Li, Xusheng Wang, Suresh Poudel, Hong Wang, Dey, Kaushik Kumar, Ping‐Chung Chen, Ka Yang, Junmin Peng · 2021 · Figshare
34. Unraveling Alzheimer's disease heterogeneity:
    Eleonora M. Vromen · 2024
35. Mass Spectrometry-Based Methods in CNS Drug Discovery
    Gonzalo Blasco, Rudy Schreiber, Daan van Kruining · 2024 · Springer eBooks
36. Gas-phase fractionation DDA promotes in-depth DIA phosphoproteome analysis
    Zhiwei Tu, Yabin Li, Shuhui Ji, Shanshan Wang, Rui Zhou, Gertjan Kramer, Yu Cui, Fei Xie · 2025 · Heliyon
37. Early Detection of Alzheimer's Disease Using Artificial Intelligence Based on CSF Biomarkers & MRI Images
    Aya Chahal, Khaled Almir, Ahmad Diab, Firas Zakaria, Lara Hamawy · 2024 · International Conference on Smart Systems and Power Management (IC2SPM)
38. A comprehensive view of the molecular features within the serum and serum EV of Alzheimer's disease
    Jiayi Zhang, Xiaoqin Cheng, Anqi Hu, Xin Zhang, Meng Zhang, Lei Zhang, Jiawei Dai, Guoquan Yan, Huali Shen, Guoqiang Fei · 2025 · The Analyst
39. Liquid gold
    Celien Tigchelaar · 2025
40. Proteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease
    Huiming Zhu, Minqi Cai, Dezhu Chen, Jiaojiao Sha, Liang Du, Yiqiang Chen, Siyuan Liu, Qian Zheng, Xuefei Wei, Bing Bai · 2025 · Springer eBooks
41. Biomarker Modelling in Omics Technologies Using Symbolic Regression
    David Rojas-Velázquez, Alberto Paolo Tonda, Alejandro Lopez‐Rincon · 2025 · Genetic and Evolutionary Computation Conference Companion (GECCO Companion)
42. Profiling glycoproteins enriched by surface-functionalized nanoparticles
    Emmajay Sutherland, Tim S. Veth, Kayla A. Markuson, Anna G. Duboff, Nicholas McIlvain Riley · 2025 · ChemRxiv
43. Aβ Modulates Extracellular Vesicles Proteomic Profile Impacting Phosphorylation Mediators
    Margarida Vaz, Tânia Soares Martins, Diogo Trigo, Odete A. B. da Cruz e Silva, Francisco Manuel Lemos Amado, Rui Miguel Pinheiro Vitorino, Ana Gabriela Henriques · 2025 · Molecular Neurobiology
44. Additional file 1 of Plasma proteome profiling identifies changes associated to AD but not to FTD
    Rosha Babapour Mofrad, del Campo, M., Carel F.W. Peeters, Lieke H. H. Meeter, Harro Seelaar, Koel-Simmelink, M., Inez H.G.B. Ramakers, Middelkoop, H. A. M., De Deyn, P. P., Claassen, J. A. H. R. et al. · 2022 · Figshare
45. Additional file 4 of Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
    Erica S. Modeste, Lingyan Ping, Caroline M Watson, Duong, Duc M., Eric B. Dammer, Erik C B Johnson, Roberts, Blaine R., James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2024 · Figshare
46. Additional file 2 of Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
    Nina Rostgaard, Olsen, Markus Harboe, Maud Eline Ottenheijm, Lylia Drici, Anja Hviid Simonsen, Peter Plomgaard, Hanne Gredal, Helle Harding Poulsen, Henrik Zetterberg, Kaj Blennow et al. · 2024 · Figshare
47. Additional file 1 of Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification
    Jennifer T. Aguilan, Jihyeon Lim, Sabrina Racine‐Brzostek, Joshua L. Fischer, Silvescu, Cristina, Shannon Cornett, Edward Nieves, Damodara Rao Mendu, Aliste, Carlos-Madrid, Stacia Semple et al. · 2024 · Figshare
48. Additional file 3 of Proteomic profile and predictive markers of outcome in patients with subarachnoid hemorrhage
    Sara Diana Lolansen, Nina Rostgaard, Olsen, Markus Harboe, Maud Eline Ottenheijm, Lylia Drici, Tenna Capion, Nørager, Nicolas Hernandez, Nanna MacAulay, Juhler, Marianne · 2024 · Figshare
49. Additional file 1 of Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum
    Silvia Paciotti, Anna Lidia Wojdała, Giovanni Bellomo, Andrea Toja, Elena Chipi, Sander R. Piersma, Thang V. Pham, Lorenzo Gaetani, Connie R. Jiménez, Lucilla Parnetti et al. · 2023 · Figshare
50. Additional file 2 of Plasma proteome profiling identifies changes associated to AD but not to FTD
    Rosha Babapour Mofrad, del Campo, M., Carel F.W. Peeters, Lieke H. H. Meeter, Harro Seelaar, Koel-Simmelink, M., Inez H.G.B. Ramakers, Middelkoop, H. A. M., De Deyn, P. P., Claassen, J. A. H. R. et al. · 2022 · Figshare
51. Additional file 1 of Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
    Erica S. Modeste, Lingyan Ping, Caroline M Watson, Duong, Duc M., Eric B. Dammer, Erik C B Johnson, Roberts, Blaine R., James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2024 · Figshare
52. Additional file 3 of Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
    Erica S. Modeste, Lingyan Ping, Caroline M Watson, Duong, Duc M., Eric B. Dammer, Erik C B Johnson, Roberts, Blaine R., James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2024 · Figshare
53. Additional file 1 of A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease
    Annett Boeddrich, Christian Haenig, Nancy Neuendorf, Eric Blanc, Andranik Ivanov, Kirchner, Marieluise, Philipp Schleumann, Irem Bayraktaroğlu, Matthias Richter, Christine Molenda et al. · 2023 · Figshare
54. Additional file 2 of A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer’s disease
    Annett Boeddrich, Christian Haenig, Nancy Neuendorf, Eric Blanc, Andranik Ivanov, Kirchner, Marieluise, Philipp Schleumann, Irem Bayraktaroğlu, Matthias Richter, Christine Molenda et al. · 2023 · Figshare
55. Additional file 2 of Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification
    Jennifer T. Aguilan, Jihyeon Lim, Racine-Brzostek, Sabrina, Joshua L. Fischer, Silvescu, Cristina, Shannon Cornett, Edward Nieves, Damodara Rao Mendu, Aliste, Carlos-Madrid, Stacia Semple et al. · 2024 · Figshare
56. Additional file 1 of An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease
    Christopher Clark, Loı̈c Dayon, Mojgan Masoodi, Gene L. Bowman, Julius Popp · 2021 · Figshare
57. Additional file 3 of An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease
    Christopher Clark, Loı̈c Dayon, Mojgan Masoodi, Gene L. Bowman, Julius Popp · 2021 · Figshare
58. Additional file 1 of Proteomic profile and predictive markers of outcome in patients with subarachnoid hemorrhage
    Sara Diana Lolansen, Nina Rostgaard, Olsen, Markus Harboe, Maud Eline Ottenheijm, Lylia Drici, Tenna Capion, Nørager, Nicolas Hernandez, Nanna MacAulay, Juhler, Marianne · 2024 · Figshare
59. Additional file 1 of Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
    Nina Rostgaard, Olsen, Markus Harboe, Maud Eline Ottenheijm, Lylia Drici, Anja Hviid Simonsen, Peter Plomgaard, Hanne Gredal, Helle Harding Poulsen, Henrik Zetterberg, Kaj Blennow et al. · 2024 · Figshare
60. Additional file 2 of Proteomic profile and predictive markers of outcome in patients with subarachnoid hemorrhage
    Sara Diana Lolansen, Nina Rostgaard, Olsen, Markus Harboe, Maud Eline Ottenheijm, Lylia Drici, Tenna Capion, Nørager, Nicolas Hernandez, Nanna MacAulay, Juhler, Marianne · 2024 · Figshare
61. Additional file 5 of Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification
    Jennifer T. Aguilan, Jihyeon Lim, Racine-Brzostek, Sabrina, Joshua L. Fischer, Silvescu, Cristina, Shannon Cornett, Edward Nieves, Damodara Rao Mendu, Aliste, Carlos-Madrid, Stacia Semple et al. · 2024 · Figshare
62. Additional file 3 of Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification
    Jennifer T. Aguilan, Jihyeon Lim, Sabrina Racine‐Brzostek, Joshua L. Fischer, Cristina Silvescu, Shannon Cornett, Edward Nieves, Damodara Rao Mendu, Aliste, Carlos-Madrid, Stacia Semple et al. · 2024 · Figshare
63. Additional file 2 of An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer’s disease
    Christopher Clark, Loı̈c Dayon, Mojgan Masoodi, Gene L. Bowman, Julius Popp · 2021 · Figshare
64. Additional file 4 of Effect of dynamic exclusion and the use of FAIMS, DIA and MALDI-mass spectrometry imaging with ion mobility on amyloid protein identification
    Jennifer T. Aguilan, Jihyeon Lim, Sabrina Racine‐Brzostek, Joshua L. Fischer, Cristina Silvescu, Shannon Cornett, Edward Nieves, Damodara Rao Mendu, Aliste, Carlos-Madrid, Stacia Semple et al. · 2024 · Figshare
65. Additional file 5 of Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
    Erica S. Modeste, Lingyan Ping, Caroline M Watson, Duong, Duc M., Eric B. Dammer, Erik C B Johnson, Roberts, Blaine R., James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2024 · Figshare
66. Additional file 2 of Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease
    Erica S. Modeste, Lingyan Ping, Caroline M Watson, Duong, Duc M., Eric B. Dammer, Erik C B Johnson, Roberts, Blaine R., James J. Lah, Allan I. Levey, Nicholas T. Seyfried · 2024 · Figshare
67. Body-Wide Glycolytic Shift, Oxidative Stress, and Sex-Specific Effect of Caloric Restriction in a Mouse Model of Alzheimer’s Disease
    Myroslava Vatashchuk, Viktoria Hurza, Kuang Pan, Maria M. Bayliak, Dmytro V. Gospodaryov, Volodymyr I. Lushchak, Olga Garaschuk · 2026 · Antioxidants
68. Mitochondrial dysfunction and programmed cell death in Alzheimer’s disease: A retrospective bioinformatics study
    Hua-xiong Zhang, Hong-yan Li · 2026 · Medicine
69. Myelin alterations in early stages of Alzheimer's disease and preclinical assessment of the protective and therapeutic potential of neurosteroid 3α-O-allyl-allopregnanolone
    Nwife Getrude Okechukwu · 2023 · theses.fr (ABES)
70. Reproducibility-driven discovery and systematic benchmarking reveal a robust cerebrospinal fluid proteomic signature in Alzheimer’s disease
    María Fernanda Zambrano‐Astorga, Aldo Moreno‐Ulloa, the Alzheimer’s Disease Neuroimaging Initiative · 2026 · medRxiv
71. Introduction: Stages and Progression of Alzheimer’s Disease
    Shayeri Chatterjee Ganguly, Biraj Patra · 2026 · SpringerBriefs in modern perspectives on disability research.
72. Generative AI for CSF multi-omics: Learning strategies for small-cohort classification
    Alexis Wuyart, Jean‐Marc Millot · 2026 · Neuroscience Informatics
73. Omics GWAS: A Multi‐Omics Integrative Analysis Platform for Genome‐Wide Association Studies
    Xu Zhang, Kailai Li, Yasi Zhang, Cenwen Liu, Shunyi Huang, Yingzhao Jin, Yugeng Gao, Quan Cheng, Yunyun Mei · 2026 · Med Research
74. Next-generation brain proteomics: Integrating single-cell, spatial, and multi-omics for clinical biomarker discovery
    Arup Acharjee, Nitika Rai, Akash Patel, Papia Acharjee · 2026 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
75. A shared injury–homeostasis gradient in the human CSF proteome across neurological disease
    Alireza Mansouri, Nicholas Mikolajewicz, Cécile Riviere-Cazaux, Kyle J. Tuohy, Sruthi Ranganathan, Rahul Kumar, Alexandra Miller, Manmeet Singh Ahluwalia, Paul Christopher Boutros, Chetan Bettegowda et al. · 2026 · Research Square
76. Proteomic Features and Association Analysis of Late-Onset Depression Based on Behavioral Factorial Analysis and Proteomics
    Yuqi Yan, Hanfang Xu, Tiange Zhang, Lanxin Li, Haisheng Zhou, Lihui Fan, Can Yan, Lili Wu · 2026 · Journal of Proteome Research
77. Artificial intelligence in Alzheimer's disease: From clinical biomarker intelligence to therapeutic innovation
    Juntao Wang, Zhen Li, Ting Wang, Linyin Jiang, Arazu Sharif, Ryusuke Takechi, Ting Li, Lor Huai Chong, Feifei Fang, Zhiqing Pang et al. · 2026 · Acta Pharmaceutica Sinica B
78. The application progress of artificial intelligence in the diagnosis of Alzheimer’s disease
    Enqi Liu, Meijia Cheng, Yetao Ju, Yi Ru, Yongming Liu, Dongyu Min · 2026 · Frontiers in Neurology
79. Integrating CSF and EV Proteomes Enhances Biomarker Discovery by Capturing Shared Variation Across Compartments
    Bianca R. P. Brown, Xiaoting Li, Monica R. Grasty, Andrew D. Miranker, Gamze Gürsoy · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
80. SOD1 co-pathologies in the brain: insights from neuropathological evidence and implications
    Evellyn Mayla de Azevedo, Victoria Simões Bernardo, Marcelo M. S. Lima, Elis C. A. Eleuthério, Tiago F. Outeiro · 2026 · Acta Neuropathologica
81. Differential Proteomic Profiling of Cerebrospinal Fluid Shows Potential for the Diagnosis of Degenerative Cervical Myelopathy
    Jianhua Zheng, Jinchao Wang, Xiaopeng Zhang, Liguo Liu, Qinpeng Song, Penglei Cui, Xiao Han · 2026 · PROTEOMICS - CLINICAL APPLICATIONS